Literature DB >> 29113718

Pregnancy outcomes in women with previous gestational hypertension: A cohort study to guide counselling and management.

Diane Nzelu1, Dan Dumitrascu-Biris1, Katharine F Hunt2, Mark Cordina1, Nikos A Kametas3.   

Abstract

OBJECTIVES: In pregnant women with previous gestational hypertension: to compare the prevalence of preeclampsia as defined by the 2001 versus the 2014 International Society for the Study of Hypertension in Pregnancy (ISSHP) criteria, to determine the rates of fetal growth restriction (FGR) as defined, not only by birthweight centile, but in combination with fetal ultrasound studies and, finally, to determine rates of other related outcomes such as gestational diabetes (GDM) and obstetric cholestasis (OC). STUDY
DESIGN: This was a retrospective observational study based at the Antenatal Hypertension Clinic, Kings College Hospital, London. Routinely collected data of 773 women booked between 2011 and 2016 with a history of gestational hypertension was analysed. All women were normotensive at booking and those with chronic hypertension were excluded. MAIN OUTCOMES MEASURES: Hypertensive disorders of pregnancy (ISSHP-2014), FGR, GDM.
RESULTS: Forty-nine percent developed one or more pregnancy complications, of which 72% were hypertensive disorders of pregnancy, 25.8% preeclampsia, 25% GDM and 19% FGR. Overall recurrence rate of preeclampsia was 12.5% (ISSHP-2014). Higher blood pressure and body mass index at booking were associated with higher risk of preeclampsia and GDM. Earlier gestation of previous hypertension was associated with higher risk of preeclampsia and FGR. The ISSHP-2014 compared to the 2001 guidelines classified 56% more women as having preeclampsia.
CONCLUSION: Pregnant women with a history of gestational hypertension have a 49% chance of developing a complication related to a hypertensive disorder, GDM and OC. The rate of preeclampsia was more than doubled if the updated ISSHP-2014 definition was used. Crown
Copyright © 2017. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood pressure; Fetal growth restriction; Gestational diabetes; Hypertension; International Society for the Study of Hypertension in Pregnancy; Preeclampsia; Recurrence

Mesh:

Year:  2017        PMID: 29113718     DOI: 10.1016/j.preghy.2017.10.011

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  4 in total

1.  Use of an artificial intelligence-based rule extraction approach to predict an emergency cesarean section.

Authors:  Yoko Nagayasu; Daisuke Fujita; Masahide Ohmichi; Yoichi Hayashi
Journal:  Int J Gynaecol Obstet       Date:  2021-09-06       Impact factor: 4.447

2.  Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF‑κB signaling pathway.

Authors:  Xudong Zhao; Xietong Wang
Journal:  Mol Med Rep       Date:  2018-05-23       Impact factor: 2.952

3.  Postnatal assessment for renal dysfunction in women with hypertensive disorders of pregnancy : A prospective observational study.

Authors:  Emmanouil Kountouris; Katherine Clark; Polly Kay; Nadia Roberts; Kate Bramham; Nikos A Kametas
Journal:  J Nephrol       Date:  2021-09-24       Impact factor: 3.902

4.  Gestational Diabetes Mellitus in Europe: A Systematic Review and Meta-Analysis of Prevalence Studies.

Authors:  Marília Silva Paulo; Noor Motea Abdo; Rita Bettencourt-Silva; Rami H Al-Rifai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-09       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.